製品名
Anti-RSV Antibody, fusion protein, all type A, B strains, clone 133-1H, clone 133-1H, Chemicon®, from mouse
biological source
mouse
antibody form
purified immunoglobulin
antibody product type
primary antibodies
clone
133-1H, monoclonal
species reactivity
human
manufacturer/tradename
Chemicon®
technique(s)
ELISA: suitable
immunofluorescence: suitable
isotype
IgG2aκ
shipped in
wet ice
Quality Level
Application
Anti-RSV Antibody, fusion protein, all type A, B strains, clone 133-1H is an antibody against Respiratory Syncytial Virus for use in ELISA & IF.
ELISA, Indirect Immunofluorescence
Optimal working dilutions must be determined by the end user.
Optimal working dilutions must be determined by the end user.
Research Category
Infectious Diseases
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral
Infectious Diseases - Viral
Biochem/physiol Actions
Directed against the 47-49 kDa Fusion Protein of RSV. Antibody MAB858-1 recognizes both A and B RSV strains.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Immunogen
Respiratory Syncytial virus A2
Other Notes
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Physical form
Format: Purified
Purified. Liquid 0.02M PBS, 0.25M NaCl, 0.1% sodium azide
Preparation Note
Store at 2 to 8°C for up to 12 months from date of receipt.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
適切な製品が見つかりませんか。
製品選択ツール.をお試しください
保管分類
10 - Combustible liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
試験成績書(COA)
製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
Respiratory syncytial virus NS1 protein colocalizes with mitochondrial antiviral signaling protein MAVS following infection.
Boyapalle, S; Wong, T; Garay, J; Teng, M; San Juan-Vergara, H; Mohapatra, S; Mohapatra, S
Testing null
A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism.
Krarup, A; Truan, D; Furmanova-Hollenstein, P; Bogaert, L; Bouchier, P; Bisschop et al.
Nature Communications null
Bárbara N Porto et al.
Viruses, 13(10) (2021-10-27)
Respiratory Syncytial Virus (RSV) is the leading cause of acute lower respiratory infections in young children and infection has been linked to the development of persistent lung disease in the form of wheezing and asthma. Despite substantial research efforts, there
Catherine A A Beauchemin et al.
PloS one, 14(4), e0214708-e0214708 (2019-04-16)
Many aspects of the respiratory syncytial virus (RSV) are still poorly understood. Yet these knowledge gaps have had and could continue to have adverse, unintended consequences for the efficacy and safety of antivirals and vaccines developed against RSV. Mathematical modelling
グローバルトレードアイテム番号
| カタログ番号 | GTIN |
|---|---|
| MAB8262 | 04053252723148 |
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら(テクニカルサービス)